vs
Angel Studios, Inc.（ANGX）与PUMA BIOTECHNOLOGY, INC.（PBYI）财务数据对比。点击上方公司名可切换其他公司
Angel Studios, Inc.的季度营收约是PUMA BIOTECHNOLOGY, INC.的1.5倍（$109.9M vs $75.5M），Angel Studios, Inc.同比增速更快（254.3% vs 27.7%）
Angel Studios, Inc.是一家总部位于美国犹他州普罗沃的独立媒体公司与影视发行制片厂，主营业务为院线影片的制作与发行，同时运营名为Angel的OTT视频点播流媒体服务。该流媒体服务面向全球开放，用户可通过网页浏览器，以及智能手机、平板、智能电视上的客户端访问使用。
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
ANGX vs PBYI — 直观对比
营收规模更大
ANGX
是对方的1.5倍
$75.5M
营收增速更快
ANGX
高出226.6%
27.7%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $109.9M | $75.5M |
| 净利润 | $-78.6M | — |
| 毛利率 | 60.2% | 69.3% |
| 营业利润率 | -64.5% | 22.7% |
| 净利率 | -71.5% | — |
| 营收同比 | 254.3% | 27.7% |
| 净利润同比 | -111.5% | — |
| 每股收益（稀释后） | $-0.47 | $0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ANGXPBYI
| Q4 25 | $109.9M | $75.5M | ||
| Q3 25 | $76.5M | $54.5M | ||
| Q2 25 | — | $52.4M | ||
| Q1 25 | — | $46.0M | ||
| Q4 24 | — | $59.1M | ||
| Q3 24 | $20.1M | $80.5M | ||
| Q2 24 | — | $47.1M | ||
| Q1 24 | — | $43.8M |
净利润ANGXPBYI
| Q4 25 | $-78.6M | — | ||
| Q3 25 | $-38.6M | $8.8M | ||
| Q2 25 | — | $5.9M | ||
| Q1 25 | — | $3.0M | ||
| Q4 24 | — | — | ||
| Q3 24 | $-13.9M | $20.3M | ||
| Q2 24 | — | $-4.5M | ||
| Q1 24 | — | $-4.8M |
毛利率ANGXPBYI
| Q4 25 | 60.2% | 69.3% | ||
| Q3 25 | 55.1% | 77.7% | ||
| Q2 25 | — | 76.5% | ||
| Q1 25 | — | 77.1% | ||
| Q4 24 | — | 76.4% | ||
| Q3 24 | 59.7% | 63.9% | ||
| Q2 24 | — | 77.4% | ||
| Q1 24 | — | 75.5% |
营业利润率ANGXPBYI
| Q4 25 | -64.5% | 22.7% | ||
| Q3 25 | -49.8% | 17.6% | ||
| Q2 25 | — | 12.7% | ||
| Q1 25 | — | 8.7% | ||
| Q4 24 | — | 22.6% | ||
| Q3 24 | -75.3% | 27.4% | ||
| Q2 24 | — | -4.6% | ||
| Q1 24 | — | -5.3% |
净利率ANGXPBYI
| Q4 25 | -71.5% | — | ||
| Q3 25 | -50.4% | 16.2% | ||
| Q2 25 | — | 11.2% | ||
| Q1 25 | — | 6.5% | ||
| Q4 24 | — | — | ||
| Q3 24 | -68.9% | 25.2% | ||
| Q2 24 | — | -9.6% | ||
| Q1 24 | — | -11.0% |
每股收益（稀释后）ANGXPBYI
| Q4 25 | $-0.47 | $0.26 | ||
| Q3 25 | $-0.25 | $0.17 | ||
| Q2 25 | — | $0.12 | ||
| Q1 25 | — | $0.06 | ||
| Q4 24 | — | $0.40 | ||
| Q3 24 | $-0.10 | $0.41 | ||
| Q2 24 | — | $-0.09 | ||
| Q1 24 | — | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $44.1M | $97.5M |
| 总债务越低越好 | — | $22.7M |
| 股东权益账面价值 | $-25.8M | $130.3M |
| 总资产 | $241.4M | $216.3M |
| 负债/权益比越低杠杆越低 | — | 0.17× |
8季度趋势，按日历期对齐
现金及短期投资ANGXPBYI
| Q4 25 | $44.1M | $97.5M | ||
| Q3 25 | $63.3M | $94.4M | ||
| Q2 25 | — | $96.0M | ||
| Q1 25 | — | $93.2M | ||
| Q4 24 | — | $101.0M | ||
| Q3 24 | — | $96.7M | ||
| Q2 24 | — | $96.8M | ||
| Q1 24 | — | $107.2M |
总债务ANGXPBYI
| Q4 25 | — | $22.7M | ||
| Q3 25 | — | $34.0M | ||
| Q2 25 | — | $45.3M | ||
| Q1 25 | — | $56.7M | ||
| Q4 24 | — | $68.0M | ||
| Q3 24 | — | $79.3M | ||
| Q2 24 | — | $90.7M | ||
| Q1 24 | — | $102.0M |
股东权益ANGXPBYI
| Q4 25 | $-25.8M | $130.3M | ||
| Q3 25 | $37.2M | $115.3M | ||
| Q2 25 | — | $104.7M | ||
| Q1 25 | — | $97.1M | ||
| Q4 24 | — | $92.1M | ||
| Q3 24 | $-5.0M | $71.1M | ||
| Q2 24 | — | $48.5M | ||
| Q1 24 | — | $51.0M |
总资产ANGXPBYI
| Q4 25 | $241.4M | $216.3M | ||
| Q3 25 | $197.0M | $202.9M | ||
| Q2 25 | — | $194.9M | ||
| Q1 25 | — | $196.2M | ||
| Q4 24 | — | $213.3M | ||
| Q3 24 | $13.5M | $220.7M | ||
| Q2 24 | — | $205.0M | ||
| Q1 24 | — | $214.1M |
负债/权益比ANGXPBYI
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.30× | ||
| Q2 25 | — | 0.43× | ||
| Q1 25 | — | 0.58× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 1.12× | ||
| Q2 24 | — | 1.87× | ||
| Q1 24 | — | 2.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $14.4M |
| 自由现金流经营现金流 - 资本支出 | — | $14.4M |
| 自由现金流率自由现金流/营收 | — | 19.1% |
| 资本支出强度资本支出/营收 | — | 0.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $41.7M |
8季度趋势，按日历期对齐
经营现金流ANGXPBYI
| Q4 25 | — | $14.4M | ||
| Q3 25 | $-58.1M | $9.7M | ||
| Q2 25 | — | $14.1M | ||
| Q1 25 | — | $3.6M | ||
| Q4 24 | — | $15.6M | ||
| Q3 24 | $-37.7M | $11.0M | ||
| Q2 24 | — | $1.0M | ||
| Q1 24 | — | $11.2M |
自由现金流ANGXPBYI
| Q4 25 | — | $14.4M | ||
| Q3 25 | — | $9.7M | ||
| Q2 25 | — | $14.1M | ||
| Q1 25 | — | $3.6M | ||
| Q4 24 | — | $15.6M | ||
| Q3 24 | — | $11.0M | ||
| Q2 24 | — | $1.0M | ||
| Q1 24 | — | — |
自由现金流率ANGXPBYI
| Q4 25 | — | 19.1% | ||
| Q3 25 | — | 17.7% | ||
| Q2 25 | — | 26.8% | ||
| Q1 25 | — | 7.7% | ||
| Q4 24 | — | 26.4% | ||
| Q3 24 | — | 13.7% | ||
| Q2 24 | — | 2.1% | ||
| Q1 24 | — | — |
资本支出强度ANGXPBYI
| Q4 25 | — | 0.0% | ||
| Q3 25 | — | 0.0% | ||
| Q2 25 | — | 0.0% | ||
| Q1 25 | — | 0.1% | ||
| Q4 24 | — | 0.0% | ||
| Q3 24 | — | 0.0% | ||
| Q2 24 | — | 0.0% | ||
| Q1 24 | — | 0.0% |
现金转化率ANGXPBYI
| Q4 25 | — | — | ||
| Q3 25 | — | 1.10× | ||
| Q2 25 | — | 2.41× | ||
| Q1 25 | — | 1.21× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.54× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ANGX
| Licensed content and other revenue | $109.8M | 100% |
| Pay it Forward revenue | $163.7K | 0% |
PBYI
暂无分部数据
